Distinct features of AV, AAV and LV vectors. AdV, AAV and LV vectors

Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical in vivo studies - Laura Skukan, Matea Brezak, Rok Ister, Lars Klimaschewski, Aleksandar Vojta, Vlatka Zoldoš, Srećko Gajović

Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye

In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans: Molecular Therapy - Methods & Clinical Development

Gene therapy and editing for the retina: A primer

Physicochemical Methods for Vectors and Ancillary Materials in Cellular and Gene Therapies

The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors

Overview of gene therapy vectors and target cells and tissues for

Viral vector-based vaccine; DNA-based vaccine; RNA based vaccine - A landscape for vaccine technology against infectious disease, COVID-19 and tumor

Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors - ScienceDirect

Comparing Gene Transfer Tools: AAV vs. Lentiviral Vectors

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer - ScienceDirect

Manufacturing Challenges with AAV-Based Gene Therapies - BioProcess InternationalBioProcess International